+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Autotransfusion System Market - Global Forecast 2026-2032- Product Image
Autotransfusion System Market - Global Forecast 2026-2032- Product Image
Sale

Autotransfusion System Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 4858017
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Autotransfusion System Market is projected to reach USD 867.13 Million in 2026. It is expected to continue growing at a CAGR of 7.38%, reaching USD 1.33 Billion by 2032.

Autotransfusion systems are becoming a strategic component of modern patient blood management as hospitals seek to reduce exposure to allogeneic blood, improve perioperative resilience, and support safer care in high-blood-loss procedures. These systems collect, process, wash, and reinfuse a patient’s own blood during or after surgery, making them particularly relevant in cardiovascular, orthopedic, trauma, transplant, obstetric, and major oncologic procedures where blood conservation is clinically important.

The market is shaped by evidence-based clinical guidelines, hospital quality programs, blood supply constraints, and rising demand for surgical efficiency. Organizations such as the World Health Organization, AABB, and professional anesthesia and surgical societies continue to emphasize patient blood management, restrictive transfusion strategies, and optimized perioperative care. Within this framework, autotransfusion systems support reduced donor blood dependence, immunologic compatibility, and continuity of care when compatible blood availability is limited.

Transformative Shifts in the Autotransfusion Landscape

The autotransfusion system landscape is shifting from device-centered procurement to integrated blood management strategies. Hospitals are evaluating systems not only on processing speed and wash quality, but also on workflow integration, disposables availability, training burden, service reliability, hemolysis control, anticoagulation protocols, and compatibility with operating room workflows.

Transformative changes include greater adoption of cell salvage in complex surgeries, increased focus on closed-loop perioperative data, and stronger regulatory expectations for device safety, sterility, traceability, and post-market surveillance. Supply chain volatility and periodic blood shortages have further strengthened the case for autologous blood recovery, especially in high-acuity centers and trauma networks where timely access to compatible blood can influence clinical operations.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence the autotransfusion ecosystem through predictive analytics, workflow optimization, inventory forecasting, and perioperative decision support. AI-enabled hospital platforms can help identify patients at high risk of transfusion, support preoperative anemia management, flag procedure-specific blood conservation needs, and optimize resource allocation across operating rooms and blood banks.

The cumulative impact is strongest where AI is connected to electronic health records, surgical scheduling, laboratory values, hemodynamic data, and blood utilization records. While autotransfusion devices remain governed by strict safety and regulatory controls, AI can improve surrounding processes, including preventive maintenance planning, staff training analytics, adverse-event surveillance, protocol adherence monitoring, and evidence generation for value-based procurement.

Key Regional Insights Across Global Autotransfusion Demand

Asia-Pacific is expanding as China, India, Japan, South Korea, Australia, and ASEAN markets invest in surgical infrastructure, trauma care, cardiovascular services, and blood conservation programs. Japan, South Korea, and Australia show mature demand patterns supported by advanced operating room capabilities and quality-driven procurement, while China and India are advancing through hospital expansion, rising surgical access, and stronger attention to blood safety and perioperative efficiency.

North America demonstrates strong adoption potential due to established patient blood management programs, advanced trauma systems, high surgical volumes, and mature reimbursement and accreditation structures. The United States is particularly influential because of its large base of tertiary hospitals, cardiac centers, orthopedic programs, trauma centers, and regulatory oversight from the FDA, while Canada’s publicly funded health system supports standardized procurement and quality-driven implementation.

Latin America, led by Brazil and Mexico, is advancing through private hospital investment, broader access to specialized surgery, and growing attention to blood conservation, though adoption varies by reimbursement, public procurement capacity, and clinical infrastructure. Europe benefits from structured clinical governance, blood safety standards, and the influence of the European Union medical device regulatory framework, with Germany, France, Italy, Spain, and the United Kingdom showing demand linked to advanced surgical capacity and perioperative quality initiatives.

The Middle East, especially GCC countries, is investing in high-acuity hospital systems, cardiovascular surgery, transplant services, and medical tourism capabilities, supporting adoption in advanced referral hospitals. Africa presents long-term opportunity as surgical access, blood safety programs, and emergency care capacity improve, with autotransfusion adoption likely concentrated first in urban tertiary hospitals, trauma centers, and referral surgical networks.

Key Group Insights for Strategic Market Prioritization

ASEAN markets are becoming increasingly relevant as Indonesia, Thailand, Vietnam, Malaysia, the Philippines, and Singapore expand surgical capacity and hospital modernization programs. Demand is shaped by uneven blood supply infrastructure, growing trauma care requirements, and the rise of private hospital networks that can adopt advanced intraoperative blood recovery systems.

The GCC is positioned as a high-value group because Saudi Arabia, the United Arab Emirates, Qatar, Kuwait, Bahrain, and Oman continue investing in tertiary care, cardiovascular surgery, transplant programs, emergency preparedness, and medical tourism. The European Union provides a highly regulated environment where adoption is influenced by medical device compliance, hospital tendering, blood safety standards, and patient blood management policies.

BRICS countries combine large patient populations with expanding surgical procedure volumes, hospital infrastructure investment, and rising demand for resilient blood management systems. G7 markets offer mature technology adoption, clinical governance, and evidence-based procurement, while NATO countries represent demand linked to trauma readiness, military medicine, emergency preparedness, and the need for reliable perioperative blood conservation in civilian and defense healthcare settings.

Key Country Insights Shaping Competitive Opportunity

The United States remains the most important single-country demand center due to its concentration of advanced surgical centers, high utilization of cardiac and orthopedic procedures, mature trauma systems, and well-developed patient blood management programs. Canada emphasizes standardized hospital purchasing and quality improvement, while Mexico is progressing through private sector growth, medical tourism, and expanding access to specialized surgery.

Brazil is the leading Latin American opportunity, supported by large hospital networks and demand for complex care. The United Kingdom, Germany, France, Italy, and Spain show adoption linked to surgical excellence, blood safety standards, health technology assessment, and cost-effectiveness evaluation. Russia maintains demand through major public hospitals and specialty centers, although procurement conditions and access to imported medical technologies can vary by region and policy environment.

China and India are high-potential opportunities because of large surgical volumes, hospital expansion, rising middle-class access to advanced care, and growing clinical focus on blood conservation. Japan, South Korea, and Australia represent mature Asia-Pacific markets where technology quality, clinical evidence, training support, uptime reliability, and regulatory compliance are central to purchasing decisions.

Actionable Recommendations for Industry Leaders

Industry leaders should position autotransfusion systems as part of a broader patient blood management solution rather than a standalone surgical device. Commercial strategies should emphasize clinical outcomes, operational efficiency, reduction in allogeneic blood dependence, protocol standardization, and alignment with perioperative quality programs.

Manufacturers should invest in intuitive interfaces, faster processing, consistent wash performance, robust disposables supply, device interoperability, cybersecurity-ready connectivity, and training programs for surgical, anesthesia, perfusion, and nursing teams. Partnerships with hospitals should include implementation support, utilization audits, simulation-based training, maintenance planning, and evidence generation across cardiac, orthopedic, trauma, obstetric, oncologic, and transplant applications.

Market access teams should tailor value propositions by region, addressing FDA expectations in the United States, medical device regulatory requirements in Europe, tender-based procurement in public health systems, and affordability considerations in emerging markets. Leaders should also develop resilient supply chains for disposables, service parts, and technical support, as uninterrupted system availability is central to adoption in high-acuity surgical environments.

Research Methodology and Evidence Base

Research methodology is built on a structured secondary research approach using verified public sources, including regulatory guidance, clinical practice standards, hospital blood management literature, procurement trends, medical device safety communications, and healthcare infrastructure indicators. The analysis prioritizes evidence from recognized authorities such as the World Health Organization, AABB, national regulators, professional societies, accreditation bodies, and peer-reviewed clinical literature.

The methodology evaluates market dynamics through demand drivers, clinical use cases, regulatory frameworks, regional healthcare capacity, surgical care trends, blood safety priorities, and technology adoption patterns. Insights are triangulated across patient blood management guidance, perioperative transfusion practices, blood supply resilience, hospital procurement behavior, and device implementation requirements to ensure an evidence-led view without relying on unsupported market-size, market-share, or forecasting claims.

Conclusion: Autotransfusion Systems as a Strategic Care Enabler

The autotransfusion system market is positioned for sustained relevance as health systems pursue safer, more efficient, and more resilient blood management practices. Clinical demand is supported by high-blood-loss procedures, donor blood constraints, blood safety priorities, and the global movement toward patient-centered perioperative care.

Future competitive advantage will depend on combining device reliability, clinical evidence, workflow integration, AI-enabled decision support, training excellence, and region-specific market access strategies. Organizations that align autotransfusion systems with patient blood management outcomes, regulatory compliance, and surgical workflow efficiency will be best placed to capture demand across mature and emerging healthcare markets.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Autotransfusion System Market, by Product Type
7.1. Introduction
7.2. Autotransfusion Devices
7.2.1. Intra-Operative Autotransfusion Devices
7.2.2. Post-Operative Autotransfusion Devices
7.2.3. Pre-Operative Autotransfusion Devices
7.3. Consumables & Accessories
8. Autotransfusion System Market, by Operation
8.1. Introduction
8.2. Automated System
8.3. Semi-Automated System
8.4. Manual System
9. Autotransfusion System Market, by Technology
9.1. Introduction
9.2. Unwashed Filtered Blood
9.3. Washed Discontinuous Flow Centrifugal
9.4. Washed Continuous Flow Centrifugal
10. Autotransfusion System Market, by Application
10.1. Introduction
10.2. Cardiac Surgery
10.2.1. Coronary Artery Bypass Grafting
10.2.2. Valve Replacement
10.3. Orthopedic Surgery
10.3.1. Joint Replacement
10.3.2. Spine Surgery
10.4. Transplant Surgery
10.5. Trauma Surgery
10.6. Vascular Surgery
10.7. Tumor Surgery
11. Autotransfusion System Market, by Patient Type
11.1. Introduction
11.2. Adult & Elderly Patients
11.3. Pediatric
12. Autotransfusion System Market, by End-User
12.1. Introduction
12.2. Ambulatory Surgery Centers
12.3. Hospitals
12.4. Specialty Clinics
13. Autotransfusion System Market, by Region
13.1. Introduction
13.2. Europe
13.3. Asia-Pacific
13.4. North America
13.5. Latin America
13.6. Middle East
13.7. Africa
14. Autotransfusion System Market, by Group
14.1. Introduction
14.2. NATO
14.3. G7
14.4. European Union
14.5. BRICS
14.6. ASEAN
14.7. GCC
15. Autotransfusion System Market, by Country
15.1. Introduction
15.2. United States
15.3. Germany
15.4. China
15.5. United Kingdom
15.6. Japan
15.7. India
15.8. France
15.9. South Korea
15.10. Canada
15.11. Australia
15.12. Italy
15.13. Spain
15.14. Brazil
15.15. Russia
15.16. Mexico
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Haemonetics Corporation
17.2. Livanova PLC
17.3. Fresenius Medical Care AG & Co. KGaA
17.4. Medtronic PLC
17.5. Zimmer Biomet Holdings, Inc.
17.6. Becton, Dickinson and Company
17.7. Beijing ZKSK Technology Co., Ltd.
17.8. i-SEP
17.9. Redax S.p.A.
17.10. Braile Biomédica
17.11. Sisu Global Health
17.12. HemoClear B.V
17.13. Advancis Medical by Brightwake Limited
17.14. Carolina Autotransfusion, Inc.
17.15. Gen World Medical Devices
17.16. Global Blood Resources, LLC
17.17. ProCell Surgical Inc.
17.18. Sarstedt AG & Co. KG
17.19. SpecialtyCare
18. Key Experts
List of Figures
FIGURE 1. Global Autotransfusion System Market, Years Considered for the Study
FIGURE 2. Global Autotransfusion System Market, Research Design
FIGURE 3. Global Autotransfusion System Market, Research Framework
FIGURE 4. Global Autotransfusion System Market, Data Triangulation
FIGURE 5. Global Autotransfusion System Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Autotransfusion System Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Autotransfusion System Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Autotransfusion System Market Size, by Operation, 2025 vs 2032 (%)
FIGURE 9. Global Autotransfusion System Market Size, by Operation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Autotransfusion System Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 11. Global Autotransfusion System Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Autotransfusion System Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Autotransfusion System Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Autotransfusion System Market Size, by Patient Type, 2025 vs 2032 (%)
FIGURE 15. Global Autotransfusion System Market Size, by Patient Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Autotransfusion System Market Size, by End-User, 2025 vs 2032 (%)
FIGURE 17. Global Autotransfusion System Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Autotransfusion System Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Autotransfusion System Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Autotransfusion System Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Autotransfusion System Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Autotransfusion System Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Autotransfusion System Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Autotransfusion System Market Segmentation & Coverage
TABLE 2. Global Autotransfusion System Market Size, 2017-2032 (USD Million)
TABLE 3. Global Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Autotransfusion Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Autotransfusion Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Autotransfusion Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Intra-Operative Autotransfusion Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Intra-Operative Autotransfusion Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Intra-Operative Autotransfusion Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Post-Operative Autotransfusion Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Post-Operative Autotransfusion Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Post-Operative Autotransfusion Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Pre-Operative Autotransfusion Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Pre-Operative Autotransfusion Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Pre-Operative Autotransfusion Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Consumables & Accessories Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Consumables & Accessories Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Consumables & Accessories Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 20. Global Automated System Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Automated System Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Automated System Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Semi-Automated System Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Semi-Automated System Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Semi-Automated System Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Manual System Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Manual System Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Manual System Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 30. Global Unwashed Filtered Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Unwashed Filtered Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Unwashed Filtered Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Washed Discontinuous Flow Centrifugal Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Washed Discontinuous Flow Centrifugal Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Washed Discontinuous Flow Centrifugal Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Washed Continuous Flow Centrifugal Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Washed Continuous Flow Centrifugal Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Washed Continuous Flow Centrifugal Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 40. Global Cardiac Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Cardiac Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Cardiac Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Coronary Artery Bypass Grafting Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Coronary Artery Bypass Grafting Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Coronary Artery Bypass Grafting Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Valve Replacement Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Valve Replacement Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Valve Replacement Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Orthopedic Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Orthopedic Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Orthopedic Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Joint Replacement Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Joint Replacement Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Joint Replacement Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Spine Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Spine Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Spine Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Transplant Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Transplant Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Transplant Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Trauma Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Trauma Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Trauma Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Vascular Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Vascular Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Vascular Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Tumor Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Tumor Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Tumor Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 71. Global Adult & Elderly Patients Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Adult & Elderly Patients Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Adult & Elderly Patients Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 78. Global Ambulatory Surgery Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Ambulatory Surgery Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Ambulatory Surgery Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Autotransfusion System Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Europe Autotransfusion System Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Europe Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 90. Europe Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 91. Europe Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 92. Europe Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 93. Europe Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 94. Europe Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 95. Europe Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 96. Europe Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 97. Europe Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Autotransfusion System Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 108. North America Autotransfusion System Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. North America Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 110. North America Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 111. North America Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 112. North America Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 113. North America Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 114. North America Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 115. North America Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 116. North America Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 117. North America Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 118. Latin America Autotransfusion System Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Latin America Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 120. Latin America Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 121. Latin America Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 122. Latin America Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 123. Latin America Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 124. Latin America Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 125. Latin America Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 126. Latin America Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 127. Latin America Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 128. Middle East Autotransfusion System Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Middle East Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 130. Middle East Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 131. Middle East Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 132. Middle East Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 133. Middle East Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 134. Middle East Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 135. Middle East Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 136. Middle East Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 137. Middle East Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 138. Africa Autotransfusion System Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Africa Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 140. Africa Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 141. Africa Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 142. Africa Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 143. Africa Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 144. Africa Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 145. Africa Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 146. Africa Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 147. Africa Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 148. Global Autotransfusion System Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. NATO Autotransfusion System Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. NATO Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 151. NATO Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 152. NATO Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 153. NATO Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 154. NATO Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. NATO Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 156. NATO Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 157. NATO Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 158. NATO Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 159. G7 Autotransfusion System Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. G7 Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 161. G7 Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 162. G7 Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 163. G7 Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 164. G7 Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 165. G7 Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 166. G7 Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 167. G7 Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 168. G7 Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 169. European Union Autotransfusion System Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. European Union Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 171. European Union Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 172. European Union Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 173. European Union Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 174. European Union Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. European Union Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 176. European Union Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 177. European Union Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 178. European Union Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 179. BRICS Autotransfusion System Market Size, by Group, 2017-2032 (USD Million)
TABLE 180. BRICS Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 181. BRICS Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 182. BRICS Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 183. BRICS Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 184. BRICS Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 185. BRICS Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 186. BRICS Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 187. BRICS Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 188. BRICS Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 189. ASEAN Autotransfusion System Market Size, by Group, 2017-2032 (USD Million)
TABLE 190. ASEAN Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 191. ASEAN Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 192. ASEAN Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 193. ASEAN Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 194. ASEAN Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 195. ASEAN Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 196. ASEAN Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 197. ASEAN Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 198. ASEAN Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 199. GCC Autotransfusion System Market Size, by Group, 2017-2032 (USD Million)
TABLE 200. GCC Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 201. GCC Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 202. GCC Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 203. GCC Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 204. GCC Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 205. GCC Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 206. GCC Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 207. GCC Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 208. GCC Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 209. Global Autotransfusion System Market Size, by Country, 2017-2032 (USD Million)
TABLE 210. United States Autotransfusion System Market Size, 2017-2032 (USD Million)
TABLE 211. United States Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 212. United States Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 213. United States Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 214. United States Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 215. United States Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 216. United States Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 217. United States Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 218. United States Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 219. United States Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 220. Germany Autotransfusion System Market Size, 2017-2032 (USD Million)
TABLE 221. Germany Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 222. Germany Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 223. Germany Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 224. Germany Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 225. Germany Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. Germany Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 227. Germany Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 228. Germany Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 229. Germany Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 230. China Autotransfusion System Market Size, 2017-2032 (USD Million)
TABLE 231. China Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 232. China Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 233. China Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 234. China Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 235. China Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 236. China Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 237. China Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 238. China Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 239. China Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 240. United Kingdom Autotransfusion System Market Size, 2017-2032 (USD Million)
TABLE 241. United Kingdom Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 242. United Kingdom Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 243. United Kingdom Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 244. United Kingdom Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 245. United Kingdom Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 246. United Kingdom Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 247. United Kingdom Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 248. United Kingdom Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 249. United Kingdom Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 250. Japan Autotransfusion System Market Size, 2017-2032 (USD Million)
TABLE 251. Japan Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 252. Japan Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 253. Japan Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 254. Japan Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 255. Japan Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 256. Japan Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 257. Japan Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 258. Japan Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 259. Japan Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 260. India Autotransfusion System Market Size, 2017-2032 (USD Million)
TABLE 261. India Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 262. India Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 263. India Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 264. India Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 265. India Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 266. India Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 267. India Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 268. India Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 269. India Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 270. France Autotransfusion System Market Size, 2017-2032 (USD Million)
TABLE 271. France Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 272. France Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 273. France Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 274. France Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 275. France Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 276. France Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 277. France Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 278. France Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 279. France Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 280. South Korea Autotransfusion System Market Size, 2017-2032 (USD Million)
TABLE 281. South Korea Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 282. South Korea Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 283. South Korea Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 284. South Korea Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 285. South Korea Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 286. South Korea Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 287. South Korea Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 288. South Korea Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 289. South Korea Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 290. Canada Autotransfusion System Market Size, 2017-2032 (USD Million)
TABLE 291. Canada Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 292. Canada Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 293. Canada Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 294. Canada Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 295. Canada Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 296. Canada Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 297. Canada Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 298. Canada Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 299. Canada Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 300. Australia Autotransfusion System Market Size, 2017-2032 (USD Million)
TABLE 301. Australia Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 302. Australia Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 303. Australia Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 304. Australia Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 305. Australia Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 306. Australia Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 307. Australia Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 308. Australia Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 309. Australia Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 310. Italy Autotransfusion System Market Size, 2017-2032 (USD Million)
TABLE 311. Italy Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 312. Italy Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 313. Italy Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 314. Italy Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 315. Italy Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 316. Italy Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 317. Italy Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 318. Italy Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 319. Italy Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 320. Spain Autotransfusion System Market Size, 2017-2032 (USD Million)
TABLE 321. Spain Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 322. Spain Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 323. Spain Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 324. Spain Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 325. Spain Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 326. Spain Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 327. Spain Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 328. Spain Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 329. Spain Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 330. Brazil Autotransfusion System Market Size, 2017-2032 (USD Million)
TABLE 331. Brazil Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 332. Brazil Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 333. Brazil Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 334. Brazil Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 335. Brazil Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 336. Brazil Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 337. Brazil Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 338. Brazil Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 339. Brazil Autotransfusion System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 340. Russia Autotransfusion System Market Size, 2017-2032 (USD Million)
TABLE 341. Russia Autotransfusion System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 342. Russia Autotransfusion System Market Size, by Autotransfusion Devices, 2017-2032 (USD Million)
TABLE 343. Russia Autotransfusion System Market Size, by Operation, 2017-2032 (USD Million)
TABLE 344. Russia Autotransfusion System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 345. Russia Autotransfusion System Market Size, by Application, 2017-2032 (USD Million)
TABLE 346. Russia Autotransfusion System Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 347. Russia Autotransfusion System Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 348. Russia Autotransfusion System Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 349. Russia

Companies Mentioned

  • Haemonetics Corporation
  • Livanova PLC
  • Fresenius Medical Care AG & Co. KGaA
  • Medtronic PLC
  • Zimmer Biomet Holdings, Inc.
  • Becton, Dickinson and Company
  • Beijing ZKSK Technology Co., Ltd.
  • i-SEP
  • Redax S.p.A.
  • Braile Biomédica
  • Sisu Global Health
  • HemoClear B.V
  • Advancis Medical by Brightwake Limited
  • Carolina Autotransfusion, Inc.
  • Gen World Medical Devices
  • Global Blood Resources, LLC
  • ProCell Surgical Inc.
  • Sarstedt AG & Co. KG
  • SpecialtyCare

Table Information

Report AttributeDetails
No. of Pages181
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 867.13 Million
Forecasted Market Value ( USD ) by 2032 $ 1330 Million
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned19

Related Topics

Related Reports

Cardiopulmonary Autotransfusion Systems Market - Global Forecast 2026-2032 - Product Image

Cardiopulmonary Autotransfusion Systems Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Autotransfusion Systems - Global Strategic Business Report - Product Image

Autotransfusion Systems - Global Strategic Business Report

  • Report
  • 144 Pages
  • Global
From
Cardiopulmonary Autotransfusion Systems - Global Strategic Business Report - Product Image

Cardiopulmonary Autotransfusion Systems - Global Strategic Business Report

  • Report
  • 195 Pages
  • Global
From
Autotransfusion Devices Market Report 2026 - Product Image

Autotransfusion Devices Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Autotransfusion Systems - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Autotransfusion Systems - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From

About the Autotransfusion Equipment Market

Autotransfusion Equipment is a type of medical device used to collect, process, and reinfuse a patient's own blood during surgery. This process is known as autologous transfusion and is used to reduce the risk of transfusion-related complications. Autotransfusion Equipment typically consists of a collection device, a centrifuge, and a reinfusion device. The collection device is used to collect the patient's blood during surgery, the centrifuge is used to separate the red blood cells from the plasma, and the reinfusion device is used to return the red blood cells to the patient. Autotransfusion Equipment is used in a variety of surgical procedures, including cardiac, orthopedic, and trauma surgeries. It is also used in the treatment of anemia and other blood disorders. Autotransfusion Equipment is becoming increasingly popular due to its safety and cost-effectiveness. Some companies in the Autotransfusion Equipment market include Haemonetics Corporation, Fresenius Kabi, Terumo BCT, and LivaNova. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.